Skip to content

Clinical research

Clinical trial sites in Europe

Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.

  • Trial site
  • Group of pins (click to zoom)

Showing the 40,000 busiest of 474,077 located sites. The map holds only the first 40,000, so narrow the filters to see the rest.

Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.

Looking for contract research suppliers and CROs? Visit Contract Research Map

Looking to track new and ongoing clinical trials? Visit Trial Insights

Filters: Region: Europe Clear all

Trial sites by region

Select a bar to filter by region.

Scale
Trial sites by region
CategoryTrial sites
Europe474,077
North America335,544
Asia-Pacific156,891
Latin America45,783
Africa19,488
Middle East14,332
Other3,142

Top countries

Country of the site's address. Select a bar to filter.

Scale

Bar colour shows the country's region, as in the chart by region.

Trial sites by country
CategoryTrial sites
France73,197
Germany73,176
Italy48,496
Spain36,445
United Kingdom32,416
Poland26,048
Russia20,290
Turkey (Türkiye)18,573

Trial sites

474,077 sites. Sites with a public page link to it on Pharma Observatory.

  • Coltea Clinical Hospital Bucharest, Romania Ongoing trial 20 trials
  • Copernicus Podmiot Leczniczy Sp. z o.o. Gdansk, Poland Ongoing trial 20 trials
  • Deventer Hospital Deventer, Netherlands Ongoing trial 20 trials
  • Ersta Hospital Stockholm, Sweden Ongoing trial 20 trials
  • Etlik City Hospital Ankara, Turkey (Türkiye) Ongoing trial 20 trials
  • Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica Banská Bystrica, Slovakia Ongoing trial 20 trials
  • Fondazione I.R.C.C.S. Policlinico San Matteo Pavia, Italy Ongoing trial 20 trials
  • Fondazione IRCCS Policlinico San Matteo di Pavia Pavia, Italy Ongoing trial 20 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Debrecen, Hungary 20 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom 20 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France 20 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brno, Czechia 20 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy 20 trials
  • Fundació Puigvert Barcelona, Spain Ongoing trial 20 trials
  • GH Paris Saint-Joseph Paris, France Ongoing trial 20 trials
  • GSK Investigational Site Karlskrona, Sweden Ongoing trial 20 trials
  • GSK Investigational Site Cáceres, Spain Ongoing trial 20 trials
  • GSK Investigational Site Graz, Austria Ongoing trial 20 trials
  • GSK Investigational Site Deva, Romania 20 trials
  • GSK Investigational Site Leeuwarden, Netherlands Ongoing trial 20 trials

Explore the data behind the map on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.